Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440362
Status:
COMPLETED
Last Update Posted:
2008-11-10
First Post:
2007-02-23
Brief Title:
A Phase 12 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza
Sponsor:
AlphaVax Inc
Organization:
AlphaVax Inc
Organization Data
Organization:
AlphaVax Inc
Class:
INDUSTRY
Study ID:
AVX502-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AlphaVax Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Robert Olmsted PhD
Old Organization:
AlphaVax Inc